XML 63 R43.htm IDEA: XBRL DOCUMENT v3.25.1
SHARE- BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of Expense Recognized in Financial Statements
   
Year ended December 31,
 
   
2024
   
2023
   
2022
 
                   
Share-based compensation – Attributable to equity holders of the Company
  $ 363     $

526

    $
617
 
Share-based compensation – Attributable to non-controlling interests (see Note 17g)
   
1,432
     
1,351
     
569
 
                         
    $
1,795
    $
1,877
    $
1,186
 
Schedule of Number of Share Options
   
2024
   
2023 (*)
   
2022 (*)
 
   
Number of options
   
Weighted average exercise prices ($)
   
Number of options
   
Weighted average exercise prices ($)
   
Number of options
   
Weighted average exercise prices ($)
 
                                         
Outstanding at the beginning of year
   
397,452
     
28.80
     
403,603
     
41.7
     
423,395
     
55.4
 
                                                 
Granted
   
217,300
     
2.71
     
62,600
     
8.00
     
60,550
     
10.4
 
                                                 
Exercised
   
-
     
-
     
-
     
-
     
(562
)
   
10.9
 
                                                 
Forfeited
   
(20,664
)
   
41.99
     
(68,751
)
   
78.1
     
(79,780
)
   
57.5
 
                                                 

Outstanding at end of year

   
594,088
     
18.72
     
397,452
     
28.8
     
403,603
     
41.7
 
                                                 

Exercisable at end of year

   
331,746
     
29.92
     
284,183
     
34.8
     
275,528
     
53.2
 
 
(*) Number of options and weighted average exercise prices have been retroactively adjusted to reflect the reverse stock split. See Note 17(b).
Schedule of Share Options Outstanding
   
Options outstanding
 
Range of exercise prices ($)
 
Number outstanding
   
Average
remaining
contractual
life
   
Weighted
average
exercise
price
 

2.36 - 10

   
286,731
     
9.30
     
3.93
 
10.20 - 20
   
129,069
     
5.98
     
11.80
 
22.26-40.22
   
87,718
     
5.03
     
27.22
 
48.80 – 76.19
   
68,470
     
2.57
     
54.20
 
103.40 – 108.60
   
22,100
     
0.23
     
107.50
 
                         
Total
   
594,088
     
6.83
     
18.72
 
Employees Consultants and Directors [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of Assumptions Used to Value Options
   
2024
   
2023
   
2022
 
                   
Dividend yield (%)
 
-
   
-
   
-
 
Expected volatility of the share prices (%)
 
54-56
   
51-53
   
48-50
 
Risk-free interest rate (%)
 
4.21-4.56
   
3.4-4.4
   
1.5-3.5
 
Suboptimal factor
 
1.8-2
   
1.8-2
   
1.8-2
 
Post-vesting forfeiture rate (%)
 
5-20
   
5-20
   
5-20
 
Schedule of Number of Restricted Stock Units (RSU)
   
2024
   
2023 (*)
 
   
Number of RSUs
   
Weighted average grant date fair value
   
Number of RSUs
   
Weighted average grant date fair value
 
                         

Outstanding at beginning of year

   
41,420
     
12.40
     
19,658
     
25.5
 
                                 
Granted
   
1,300
     
9.67
     
35,260
     
7.50
 
                                 
Vested
   
(13,676
)
   
14.93
     
(10,423
)
   
18.7
 
                                 
Forfeited
   
(9,238
)
   
9.20
     
(3,075
)
   
20.1
 
                                 

Outstanding at end of year

   
19,806
     
11.87
     
41,420
     
12.4
 
 
(*) Number of RSUs and weighted average grant date fair value have been retroactively adjusted to reflect the reverse stock split. See Note 17(b).
Subsidiaries’ options granted to employees, directors and consultants [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of Assumptions Used to Value Options
   
2024
   
2023
 
             
Dividend yield (%)
 
-
   
-
 
Expected volatility of the share prices (%)
 
68-83
   
61-84
 
Risk-free interest rate (%)
 
3.83-4.79
   
3.52-5.05
 
Suboptimal factor
 
1.8-2.0
   
1.8-2.0
 
Post-vesting forfeiture rate (%)
 
5-10
   
5-10
 
Schedule of Number of Restricted Stock Units (RSU)
   
2024
   
2023
 
   
Number of options
   
Weighted average exercise prices ($)
   
Number of options
   
Weighted average exercise prices ($)
 
                         

Outstanding at beginning of year

   
2,531,134
     
1.63
     
2,273,489
     
1.72
 
                                 
Granted
   
151,013
     
1.42
     
854,139
     
2.10
 
                                 
Exercised
   
(5,000
)
   
0.19
     
-
     
-
 
                                 
Forfeited
   
(958,953
)
   
0.82
     
(596,494
)
   
2.68
 
                                 
Outstanding at end of year
   
1,718,194
     
2.06
     
2,531,134
     
1.63
 
                                 

Exercisable at end of year

   
1,017,367
     
2.06
     
1,530,420
     
1.09